Invention Grant
![Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors](/docs/US/2013-09-10/US08530485B2/abs.jpg.600x600.jpg)
- Patent Title: Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
-
Application No.: US13076220Application Date: 2011-03-30
-
Publication No.: US08530485B2Publication Date: 2013-09-10
- Inventor: James D. Rodgers , Stacey Shepard
- Applicant: James D. Rodgers , Stacey Shepard
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04 ; A61P35/00
![Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors](/abs-image/US/2013/09/10/US08530485B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Public/Granted literature
- US20110223210A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS Public/Granted day:2011-09-15
Information query
IPC分类:
